We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.51B
AUM Growth
+$445M
(+8.8%)
Cap. Flow
-$338M
Cap. Flow
% of AUM
-6.13%
Top 10 Holdings %
Top 10 Hldgs %
54.24%
Holding
167
New
43
Increased
28
Reduced
13
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$79.3M |
| 2 |
Merck
MRK
|
+$68.2M |
| 3 |
Vera Therapeutics
VERA
|
+$51.7M |
| 4 |
Legend Biotech
LEGN
|
+$39.5M |
| 5 |
Centene
CNC
|
+$30.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alignment Healthcare
ALHC
|
+$68M |
| 2 |
DVAX
Dynavax Technologies
DVAX
|
+$67.3M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$36.8M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
+$32.1M |
| 5 |
InMode
INMD
|
+$28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.05% |
| 2 | Real Estate | 0.41% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Rezolute
RZLT
$444M
| – | – |
-19,223
| Closed | -$55.7K |
|
152
Talkspace
TALK
$873M
| – | – |
-13,446
| Closed | -$34.4K |
|
153
Vir Biotechnology
VIR
$1.59B
| – | – |
-15,728
| Closed | -$102K |
|
154
Petco
WOOF
$760M
| – | – |
-35,446
| Closed | -$108K |
|
155
Xponential Fitness
XPOF
$279M
| – | – |
-23,097
| Closed | -$192K |
|
156
Zevra Therapeutics
ZVRA
$755M
| – | – |
-10,849
| Closed | -$81.3K |
|
|
CON
157
Concentra Group Holdings
CON
$4.04B
| – | – |
-650,000
| Closed | -$14.1M |
|
|
MTSR
158
DELISTED
Metsera Inc
MTSR
| – | – |
-500,000
| Closed | -$13.6M |
|
|
CMRX
159
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-3,771,342
| Closed | -$32.1M |
|
Similar funds
FT
GRQ
AV
PCM
VA
QC
IC
NW
Deerfield Management's Q2 2025 Portfolio in Review
As of Q2 2025, Deerfield Management held 167 positions worth $5.51B, up 8.8% from $5.06B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Deerfield Management withdrew a net $338M in Q2 2025, closing 43 positions and reducing 13 holdings. Its most notable exit was Dynavax Technologies, an estimated $67.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Deerfield Management opened a new position in Merck worth $67.9M.
- Deerfield Management's largest Q2 2025 buy was Merck: 857,724 shares worth $67.9M.
- Deerfield Management added most to United Therapeutics in Q2 2025, an estimated $79.3M increase.
- Deerfield Management's biggest Q2 2025 reduction was Alignment Healthcare, cutting an estimated $68M.
- Deerfield Management fully exited Dynavax Technologies in Q2 2025, selling an estimated $67.3M.
- Deerfield Management's ten largest holdings make up 54% of its $5.51B portfolio in Q2 2025.
- Deerfield Management opened 43 new positions and closed 43 in Q2 2025.
- Deerfield Management's portfolio value rose 8.8% quarter-over-quarter to $5.51B.
Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.